| Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ (NCT04656600) | Sanofi | 2021-03-02 |
| A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers (NCT06188325) | Sanofi | 2018-01-01 |
| A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth (NCT06193304) | Sanofi | 2014-08-25 |
| Human Placental-Derived Stem Cell Transplantation (NCT01586455) | New York Medical College | 2013-04-01 |
| Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease (NCT01427517) | University of Minnesota | 2011-07-01 |
| Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease (NCT00004293) | National Center for Research Resources (NCRR) | 1999-11-01 |
| Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease (NCT00004294) | National Center for Research Resources (NCRR) | 1999-11-01 |
| Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (NCT00005900) | Fairview University Medical Center | 1999-08-01 |
| Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease (NCT00004488) | Children's Hospital Medical Center, Cincinnati | 1998-10-01 |
| Stem Cell Transplant for Inborn Errors of Metabolism (NCT00176904) | Masonic Cancer Center, University of Minnesota | 1995-01-01 |
| Bone Response to Enzyme Replacement in Gaucher's Disease (NCT00001416) | National Institute of Neurological Disorders and Stroke (NINDS) | 1993-12-01 |
| PEG-Glucocerebrosidase for the Treatment of Gaucher Disease (NCT00001410) | National Institute of Mental Health (NIMH) | 1993-10-01 |
| Effects of Enzyme Replacement in Gaucher's Disease (NCT00001289) | National Institute of Neurological Disorders and Stroke (NINDS) | 1991-09-23 |
| Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells (NCT00001234) | National Institute of Neurological Disorders and Stroke (NINDS) | 1988-01-01 |